Dive Brief: Brii Biosciences has acquired broader rights to an experimental immunotherapy for hepatitis B developed by VBI Vaccines, as well as to the latter compa...

Biotech Fluidics has developed low volume online degassing modules for micro- and nanofluidic systems used for life science applications including dispensing, diagnos...

Biotech Fluidics announce DEGASi Prep+ - the world’s first in-line membrane degasser ready to use at 150 mL/minute with aggressive media and organic solvents. Tradit...

Biotech Fluidics has launched a new range of traceable, certified PEEK and fluoropolymer flexible tubing for use in regulated environments. Tubing is an essential pa...

Dive Brief: Eli Lilly has reached a deal to acquire Emergence Therapeutics, a German biotechnology startup focused on antibody-drug conjugates, or ADCs, the compan...

The Food and Drug Administration approved on Thursday the first gene therapy for the most common form of hemophilia, clearing the way for what patients, doctors and t...

Dive Brief: Eli Lilly announced Thursday plans to acquire one of its partners, the cell therapy developer Sigilon Therapeutics, for up to $310 million.   ...

Dive Brief: The Food and Drug Administration has for the second time rejected an experimental medicine developed by Intercept Pharmaceuticals for the fatty liver d...

The first gene therapy for Duchenne muscular dystrophy will cost $3.2 million, its developer, biotechnology company Sarepta Therapeutics, said on Thursday. The price...

Regulators who recommend whether new medicines should be approved in Europe are opposing a new ALS drug developed by the Massachusetts-based biotechnology company Amy...